Comparing cardiovascular adverse events in cancer patients: A meta-analysis of combination therapy with angiogenesis inhibitors and immune checkpoint inhibitors versus angiogenesis inhibitors alone.
Crit Rev Oncol Hematol
; 188: 104059, 2023 Aug.
Article
in En
| MEDLINE
| ID: mdl-37353178
Full text:
1
Database:
MEDLINE
Main subject:
Angiogenesis Inhibitors
/
Neoplasms
Type of study:
Clinical_trials
/
Etiology_studies
/
Systematic_reviews
Limits:
Humans
Language:
En
Year:
2023
Type:
Article